Multimedia

Adam D. Talenfeld, MD, is an attending physician at Weill Cornell Medical Center, New York Presbyterian Hospital in New York. At the 2016 Annual Scientific Meeting of the Society of Interventional Radiology, he presented data about percutaneous thermal ablation (PTA) vs surgery for small renal cancers. Here he shares some data and insights on the results. | View More
At the 2016 Annual Scientific Meeting of the Society of Interventional Radiology, Joseph Kallini, MD, clinical research fellow at Northwestern University, presented a value analysis using the 2015 American Society of Clinical Oncology framework comparing yttrium-90 radioembolization and transarterial chemoembolization. | View More
Interventional radiologists at Stanford University studied the effect of microwave ablation on portal vein and hepatic vein thrombosis in hepatocellular carcinoma and liver metastases and found the results to be encouraging for interventional oncology practice.  | View More
Riad Salem, MD, chief of interventional radiology at Northwestern University, spoke with Interventional Oncology 360 about results of a prospective randomized phase 2 study of chemoembolization versus radioembolization in hepatocellular carcinoma (the PREMIERE trial). | View More
Robert Abraham, MD, FSIR, describes a study of imageable embolic microspheres in a swine renal artery embolization study. Dr. Abraham presented 30- and 90-day results from the study at the 2016 Annual Scientific Meeting of the Society of Interventional Radiology (SIR). | View More
Franz Edward Boas, MD, PhD, an interventional radiologist at Memorial Sloan Kettering Cancer Center, describes the impetus for creating a tool for planning cryoablation procedures. | View More
David Breen, MRCP, FRCR, from Spire Southampton University Hospital in the United Kingdom, describes anecdotal evidence that cryoablation for renal cell carcinoma is equally as effective as surgery.  | View More
At the 41st Annual Scientific Meeting of the Society of Interventional Radiology (SIR), the incoming president of SIR, Charles E. Ray, MD, PhD, FSIR, spoke with Interventional Oncology 360 about the meeting and where he sees interventional radiologists going in terms of oncologic interventions.  | View More
Bradford Wood, MD, shares details on the research activities and multidisciplinary model of the Center for Interventional Oncology at the National Institutes of Health in Bethesda, Maryland.  | View More
David J. Breen, MRCP, FRCR, describes recent changes to microwave ablation devices and the way that interventional oncology clinicians are examining the quality control necessary for effective microwave ablation therapy. | View More